Skip to content

Letrozole Success Rates by Age, PCOS Status, and Cycle Count

Letrozole success rate per cycle and cumulative live birth: PALO trial numbers, age effects, BMI, PCOS vs unexplained, and when to step up. By an OB/GYN.

Reviewed May 18, 202611 min read
By Pairceive Editorial Team /Reviewed by Dr. Rumpa
Letrozole Success Rates by Age, PCOS Status, and Cycle Count

You are trying to decide whether letrozole is worth the side effects, the scans, the waiting, and the money. You want real numbers, not "results may vary." The aim of this post is to give you the letrozole success rate per cycle and cumulative, broken down by age, by polycystic ovary syndrome (PCOS) status, and by what you can expect across a four to six month treatment window.

The honest framing: the number that matters most for planning is the cumulative live-birth rate across multiple cycles, not the per-cycle figure that gets quoted on Reddit. Per-cycle numbers feel small. Cumulative numbers feel more like real life.

The headline numbers from PALO

The Pregnancy in Polycystic Ovary Syndrome II trial (the PALO trial) is still the best dataset we have on letrozole for PCOS. Legro and colleagues published it in the New England Journal of Medicine in 2014. Seven hundred and fifty women with PCOS were randomised to letrozole or clomiphene for up to five cycles.1

  • Cumulative live-birth rate over five cycles: 27.5% on letrozole (versus 19.1% on clomiphene)
  • Ovulation rate per cycle: 61.7% on letrozole (versus 48.3% on clomiphene)
  • Pregnancy rate per ovulatory cycle: roughly 17% to 22% in good responders
  • Multiple pregnancy rate: similar between groups, slightly lower with letrozole

That 27.5% is the letrozole PCOS success rate over a planned five-cycle course. It is not the per-cycle number, and that distinction matters when you are thinking about how many cycles to budget for.

Per cycle versus cumulative: why the difference matters

A per-cycle pregnancy rate of 15% to 20% sounds discouraging when you read it on a single line. The reason it is misleading is that cycles compound.

If you ovulate reliably and there are no other infertility factors, each successive cycle adds to the cumulative chance. Roughly 70% to 80% of pregnancies that happen on letrozole happen within the first three ovulatory cycles. Beyond six ovulatory cycles, additional letrozole cycles add diminishing returns, which is why most reproductive endocrinologists (REs) cap oral ovulation induction at four to six cycles before stepping up.4

So when you ask about letrozole success rate per cycle, the right framing is not "what are my odds this month" but "what are my odds across the next four to six months of consistent ovulation." If you are budgeting emotionally and financially, plan for three to four ovulatory cycles before re-evaluating.

Letrozole and trigger shot success rate

A frequent question is whether adding an hCG trigger shot changes the success rate. The honest answer is: it improves timing precision but the per-cycle pregnancy rate change is modest in PCOS when ovulation is already reliable.

Where a trigger shot helps most is when ovulation timing is uncertain. People with PCOS often have erratic luteinising hormone (LH) surges on OPKs, which makes timed intercourse a guessing exercise. A trigger removes the guessing. For couples with timed intercourse this matters because the fertile window is only a few days wide.

In the IUI setting, almost all cycles use a trigger because IUI is scheduled to a specific time. The letrozole + IUI live-birth-per-cycle numbers in the AMIGOS trial (unexplained infertility) were around 19% per cycle, with cumulative figures similar to PALO over four cycles.2

Age effects

This is the part of the post where I want to be straight with you. Age affects egg quality and ovarian reserve, and that affects every fertility treatment, including letrozole.

  • Under 35: Closest to the PALO numbers. Per-cycle pregnancy 17% to 22% when ovulating, cumulative live birth around 25% to 30% over five cycles.
  • 35 to 37: Per-cycle live birth drops by roughly a third. Cumulative live birth over five cycles closer to 18% to 22%.
  • 38 to 40: Per-cycle rates drop by roughly half from the under-35 baseline. Many REs add IUI faster in this age band rather than running multiple letrozole-only cycles.
  • 41 and older: Letrozole alone is rarely the first choice. Most clinics will either combine with IUI or move directly to IVF. Egg quality, not letrozole, is the limiting factor.5

These letrozole success rate by age estimates draw from CDC ART data and large clinic cohorts. They are not catastrophising. The drug still works. It just works against a slowly tightening backdrop after the mid-thirties, and that is worth factoring into the conversation with your RE about pace, not just dose.

PCOS versus other diagnoses

PCOS is one of the diagnoses letrozole was made for, and it shows in the data. The best response to letrozole tends to come from classic PCOS where anovulation is the only barrier to conception.

Where response gets more complicated:

  • PCOS plus mild male factor: letrozole still helps with ovulation; the conception rate depends on sperm parameters. IUI often helps here.
  • PCOS plus tubal factor: letrozole on its own cannot fix a blocked tube. If a hysterosalpingogram (HSG) has not been done, this is worth doing before assuming letrozole "failed."
  • PCOS plus endometriosis: mixed picture. Stage I and II often still respond. Stage III and IV may need a different pathway.
  • Unexplained infertility (no PCOS): letrozole is used off-label here, with or without IUI. The AMIGOS trial showed letrozole + IUI was non-inferior to clomid + IUI with fewer multiples.2

These distinctions are why letrozole pregnancy success rate cannot be a single number. The drug is the same. The biology around it is not.

Letrozole Success Rates by Age, PCOS Status, and Cycle Count: infographic
At a glance: Letrozole Success Rates by Age, PCOS Status, and Cycle Count

BMI as a modifier

Body mass index correlates with per-cycle pregnancy rates in most letrozole cohorts. Higher BMI is associated with lower per-cycle conception, particularly above a BMI of 35. This is biology, not blame.

The 2023 International Evidence-Based Guideline for PCOS recommends counselling on weight management where indicated, while also being explicit that weight is not a prerequisite for treatment.3 In my clinic experience, modest improvements in insulin sensitivity, often with the help of metformin alongside letrozole, can shift cycle response in ways that pure weight numbers do not capture.

If you are reading this and feeling shamed by clinic conversations about weight, I want to name that pattern directly. The number is one variable. It is not the only one, and it is not a moral score.

When to stop counting on letrozole

There are predictable points where most REs will recommend changing course rather than running another letrozole cycle.

  • Three to six ovulatory cycles without pregnancy: this is the standard cap.
  • Anovulatory at the maximum dose (typically 7.5mg) with or without trigger: this is letrozole-resistant PCOS, a recognised clinical phenotype.
  • Over 38 with declining ovarian reserve: continuing letrozole cycles past three is rarely the most efficient use of time.
  • Persistent factors beyond ovulation: male factor, tubal factor, or significant endometriosis usually need a different pathway.

The standard step-up options are letrozole with IUI (modest bump in success rates), letrozole with metformin in PCOS, injectable gonadotropins, or IVF. Each comes with a different cost, risk, and time profile.

What the letrozole success rate means for you

If you are about to start letrozole, the numbers worth holding in your head are these.

  • Plan for three to four ovulatory cycles before re-evaluating.
  • Most pregnancies that happen on letrozole happen by cycle 3.
  • A negative test in cycle 1 is not a failure of the drug; it is one data point.
  • If you ovulated and did not conceive, the next conversation is rarely about the dose.
  • Age, BMI, and other infertility factors all modify what these numbers mean for you specifically.

The point of citing the numbers is not to set an expectation. It is to give you a frame that protects you from extrapolating from one cycle, in either direction.

What's next

Sources

  1. Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. New England Journal of Medicine 2014;371(2):119-129. https://www.nejm.org/doi/full/10.1056/NEJMoa1313517
  2. Diamond MP, Legro RS, Coutifaris C, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility (AMIGOS trial). New England Journal of Medicine 2015;373(13):1230-1240. https://www.nejm.org/doi/full/10.1056/NEJMoa1414827
  3. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility 2023;120(4):767-793. https://doi.org/10.1016/j.fertnstert.2023.07.025
  4. Franik S, Eltrop SM, Kremer JA, Kiesel L, Farquhar C. Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2018;(5):CD010287. https://doi.org/10.1002/14651858.CD010287.pub3
  5. Centers for Disease Control and Prevention. 2021 Assisted Reproductive Technology Fertility Clinic and National Summary Report. Atlanta: US Dept of Health and Human Services, 2023. https://www.cdc.gov/art/index.html
  6. Legro RS, Kunselman AR, Brzyski RG, et al. The Pregnancy in Polycystic Ovary Syndrome II (PPCOS II) trial: rationale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of infertility in women with polycystic ovary syndrome. Contemporary Clinical Trials 2012;33(3):470-481. https://doi.org/10.1016/j.cct.2011.12.005

Common questions

What is the letrozole success rate for PCOS?

In the PALO trial, 750 women with PCOS were randomised to letrozole or clomiphene for up to five cycles, and letrozole produced a cumulative live-birth rate of 27.5% over five cycles versus 19.1% on clomiphene. That 27.5% is the planned five-cycle figure, not the per-cycle number. The ovulation rate per cycle was 61.7% on letrozole.

What is the letrozole success rate per cycle?

The pregnancy rate per ovulatory cycle is roughly 17% to 22% in good responders. A single per-cycle number sounds discouraging because cycles compound over time. The more useful framing is your odds across four to six months of consistent ovulation, so plan for three to four ovulatory cycles before re-evaluating.

Does a trigger shot improve letrozole success rates?

Adding an hCG trigger improves timing precision, but the per-cycle pregnancy rate change is modest in PCOS when ovulation is already reliable. It helps most when ovulation timing is uncertain, such as the erratic LH surges people with PCOS often have on OPKs. In IUI, almost all cycles use a trigger because IUI is scheduled to a specific time.

How does age affect letrozole success rates?

Under 35, results are closest to the PALO numbers, with per-cycle pregnancy of 17% to 22% when ovulating. At 35 to 37, per-cycle live birth drops by roughly a third, and at 38 to 40 it drops by roughly half from the under-35 baseline. At 41 and older, egg quality rather than letrozole becomes the limiting factor, and most clinics combine with IUI or move to IVF.

When should I stop trying letrozole?

Three to six ovulatory cycles without pregnancy is the standard cap, since additional cycles beyond six add diminishing returns. Being anovulatory at the maximum dose, typically 7.5mg, indicates letrozole-resistant PCOS. Persistent factors such as male factor, tubal factor, or significant endometriosis usually need a different pathway rather than another letrozole cycle.